As a guest user you are not logged in or recognized by your IP address. You have
access to the Front Matter, Abstracts, Author Index, Subject Index and the full
text of Open Access publications.
The field of medicinal chemistry involves the design, synthesis, and development of new drugs that can be further enhanced with the application of ontologies. In this paper, we discuss the need for a molecular structure ontology to aid us in the task of drug discovery. We outline a requirements-driven approach that guides us in the design of the Molecular Structure Ontology (MoSt) by which we represent atoms, bonds, functional groups, and molecules as things in the ontology. Finally, we demonstrate how the ontology can be used to axiomatize small molecules like Daraprim.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.